Adrenal Insufficiency Clinical Trial
Official title:
Characterization of the Normal Cortisol Response to Moderate and Deep Sedation in Adrenally Sufficient Children
Currently, it is unknown whether sedation itself induces a rise in serum cortisol levels or
if cortisol levels rise under only the most invasive of procedures, regardless of the type
of anesthetic agent used. Animal data shows significant alterations in steroid intermediates
under anesthesia regardless of the procedure performed. Prior studies in children show
general anesthesia and even epidural anesthesia can cause a rise in serum cortisol, but the
effects of moderate and deep sedation on cortisol levels during different types of
procedures are unknown. General medical practice varies considerably among providers; some
provide stress dosing (extra and sometimes high doses of steroids) for sedation for both
non-invasive and invasive procedures for patients with known adrenal insufficiency, but the
doses given vary considerably. Others provide stress dosing only for the most invasive
procedures in this population of patients. Currently there is no published normative data on
changes in cortisol levels under moderate and deep sedation in adrenally sufficient
children, so the normal response we are trying to mimic is unknown.
We propose to measure salivary cortisol levels prospectively in adrenally sufficient
children undergoing moderate and deep sedation to determine the normal cortisol response to
the stress of sedation for both invasive and non-invasive procedures.
Up to 300 adrenally sufficient children will be prospectively recruited to measure salivary
cortisol levels during moderate and deep sedation for non-invasive procedures (e.g. MRI,
echocardiogram, or other imaging studies), and invasive procedures (e.g. surgery, endoscopy)
to determine what the normal cortisol response is to the stress of sedation during these
procedures using various anesthetic agents.
The primary outcome variable will be to determine peak salivary cortisol measurements during
non-invasive and invasive procedures under different levels of sedation using various
anesthetic agents, and correlate these with known norms in children to determine if the
patient's hypothalamic-pituitary-adrenal axis is under stress.
Status | Completed |
Enrollment | 149 |
Est. completion date | July 2011 |
Est. primary completion date | July 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 3 Months to 18 Years |
Eligibility |
Inclusion Criteria: - Child presenting for routine sedation to the TAMC Pediatric Sedation Center. - Age 3 months to 18 years of age. - If female age 12 or greater OR menstruating, must not be pregnant. Exclusion Criteria: - Must not have the diagnosis of adrenal insufficiency or any concerns for possible adrenal insufficiency, to include recent tapering of exogenous steroids in the last 6 months. - Current treatment with oral steroids or has been on oral steroids in the last 3 months. - The use of regular inhaled corticosteroids for asthma controller treatment or intranasal steroids for allergic rhinitis is specifically NOT an exclusion criteria. |
Observational Model: Case Control, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | Tripler Army Medical Center | Honolulu | Hawaii |
Lead Sponsor | Collaborator |
---|---|
Tripler Army Medical Center |
United States,
Hsu AA, von Elten K, Chan D, Flynn T, Walker K, Barnhill J, Naun C, Pedersen AM, Ponaman M, Fredericks GJ, Crudo DF, Pinsker JE. Characterization of the cortisol stress response to sedation and anesthesia in children. J Clin Endocrinol Metab. 2012 Oct;97( — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change From Baseline to Peak Salivary Cortisol Level | Salivary cortisol will be measured prior to the sedated procedure before any intravenous lines or other stress occurs, and then every 30 minutes into the sedated procedure while the patient is being routinely suctioned. Salivary cortisol will also be measured at the end of the procedure and 30 minutes post procedure (recovery). Because many different types of procedures are performed (imaging, endoscopy, surgical) the end times of the procedures will vary for each patient. The investigators will calculate a relative change from baseline for salivary cortisol levels by comparing the peak to baseline recorded level. | Baseline, then every 30 minutes, and at end of procedure | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT03282487 -
Optimising Steroid Replacement in Patients With Adrenal Insufficiency
|
Phase 4 | |
Not yet recruiting |
NCT06435481 -
Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics
|
Phase 4 | |
Not yet recruiting |
NCT05716607 -
Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
|
N/A | |
Recruiting |
NCT03399383 -
Adherence in Chronic Adrenal Insufficiency
|
N/A | |
Completed |
NCT01428336 -
Value of 25 mcg Cortrosyn Stimulation Test
|
N/A | |
Completed |
NCT00851942 -
Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test
|
Phase 4 | |
Withdrawn |
NCT00368381 -
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
|
Phase 4 | |
Active, not recruiting |
NCT04519580 -
Improved Diagnostics and Monitoring of Polymyalgia Rheumatica
|
||
Recruiting |
NCT06008184 -
Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids
|
||
Completed |
NCT03013166 -
THIN Database Study: Resource Use and Outcomes in Patients With Adrenal Insufficiency Prescribed Hydrocortisone: Immediate, or Modified Release, or Prednisolone
|
||
Enrolling by invitation |
NCT02282150 -
Modified-release Compared to Conventional Hydrocortisone on Diurnal Fatigue in Secondary Hypoadrenalism
|
Phase 4 | |
Completed |
NCT02934399 -
Dynamic Hormone Diagnostics in Endocrine Disease
|
||
Completed |
NCT03000231 -
Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
|
||
Completed |
NCT01960530 -
An Investigational Study of Hydrocortisone
|
Phase 1 | |
Completed |
NCT00552487 -
Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis
|
N/A | |
Completed |
NCT00575341 -
Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency
|
Phase 3 | |
Completed |
NCT00471900 -
Six Months DHEA Treatment in Female Adrenal Failure
|
N/A | |
Completed |
NCT03294876 -
Rheumatoid Arthritis Adrenal Recovery Study
|
||
Completed |
NCT03709381 -
Effect of Adrenocorticotropic Hormone on Vascular Endothelial Growth Factor Release in Children Study
|
Early Phase 1 | |
Recruiting |
NCT05639127 -
The Treatment of Adrenal Crisis With Inhaled Prednisolone
|
Early Phase 1 |